Key points are not available for this paper at this time.
Design
Guideline
Answers are grounded in this paper and cite their sources.
Provides foundational CTO recanalization guidance; extends expert consensus into standardized recommendations for clinicians and trial design.
Georgios Sianos1*, MD, PhD, FESC; Gerald S. Werner2, MD, PhD, FESC, FACC, FSCI; Alfredo R. Galassi3, MD, FESC, FACC, FSCAI; Michail I. Papafaklis4, MD, PhD; Javier Escaned5, MD, PhD, FESC; David Hildick-Smith6, MD, FESC; Evald Hoj Christiansen7, MD, PhD; Anthony Gershlick8, MD, FRCP, FESC; Mauro Carlino9, MD, FESC; Angelos Karlas1, MD; Nikolaos V. Konstantinidis1, MD; Salvatore D. Tomasello3, MD; Carlo Di Mario10, MD, PhD, FRCP, FESC; Nicolaus Reifart11, MD, PhD, FESC for the EuroCTO Club
No takes yet. Share an insight, caveat, or question.
Sianos et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: